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ABSTRACT 
Background: Emotions may be important in patients’ decisions to seek medical help for 
symptoms suggestive of cancer.  
Objectives: The aim of this systematic literature review was to examine quantitative 
literature on the influence of emotion on patients’ help-seeking for symptoms suggestive of 
cancer. The objectives were to identify: (1) which types of emotions influence help-seeking 
behaviour; (2) whether these form a barrier or trigger for seeking medical help; and (3) how 
the role of emotions varies between different cancers and populations.  
 
Methods: We searched four electronic databases and conducted a narrative synthesis. 
Inclusion criteria were studies that reported primary, quantitative research that examined any 
emotion specific to symptom appraisal or help-seeking for symptoms suggestive of cancer.  
 
Results: Thirty-three papers were included. The studies were heterogeneous in their methods 
and quality and very few had emotion as the main focus of the research. Studies reported a 
limited range of emotions, mainly related to fear and worry. The impact of emotions appears 
mixed, sometimes acting as a barrier to consultation whilst at other times being a trigger or 
being unrelated to time to presentation (TTP). It is plausible that different emotions play 
different roles at different times prior to presentation. 
Conclusions: This systematic review provides some quantitative evidence for the role of 
emotions in help-seeking behaviour. However, it also highlighted widespread 
methodological, definition and design issues among the existing literature. The conflicting 
results around the role of emotions on TTP may be due to the lack of definition of each 
specific emotion. 
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INTRODUCTION 
Diagnosis of cancer at an early, localised stage is important to improve survival rates [1-3]. 
Most types of cancer are more often detected through patient presentation with symptoms 
rather than via screening programmes, and therefore timely help-seeking for symptoms 
suggestive of cancer is vital to improve patient outcomes [4]. We therefore need to improve 
our understanding of patients’ decisions to seek medical advice for symptoms suggestive of 
cancer and of factors associated with the time to presentation (TTP). We define TTP as the 
period of time between an individual’s first detection of a change in their body and the first 
consultation with a healthcare professional. This time interval has previously been described 
as ‘patient delay’ [5], but the Aarhus Statement [6] recently recommended that this term 
should be replaced by TTP as ‘delay’ indicates that patients waited to seek help, whereas 
some consult immediately after noticing symptoms [7]. Various factors such as demographics 
(e.g. age) and clinical factors (e.g. symptom type) have been shown to affect TTP [8, 9]. 
However, an individual’s appraisal of a symptom and their subsequent help-seeking 
behaviour are also based on individual decision-making, which is informed by symptom 
interpretation [10, 11] and an individual’s knowledge of cancer [12], and possibly emotions 
[13, 14]. 
The role of emotions seems less straightforward than that of cognitions: various studies have 
suggested that emotions such as fear are a barrier to seeking help [9, 15, 16], whereas others 
have indicated that emotions could promote prompt help-seeking for cancer symptoms [17, 
18]. A previous systematic review of 15 studies explored the impact of fear on ‘delay’ in 
help-seeking for symptoms of cancer and myocardial infarction [19].
 
The authors concluded 
that emotions (worry, fear and death anxiety / panic), defined by the reviewers as ‘different 
intensities of fear’, had contradicting roles in TTP [19].  In a narrative review, including 
qualitative studies, Facione [20] reported a list of various specific fears in relation to the 
discovery of breast symptoms (e.g. fear of chemotherapy, or fear of illness), and showed that 
different specific fears had different effects on TTP for breast cancer. The reasons for why 
and how specific fears may trigger or inhibit help-seeking for symptoms have not been 
studied [20]. In a qualitative synthesis by Smith and colleagues [9], a fear of cancer and a fear 
of embarrassment (including the fear of being labelled as a time-waster and embarrassment 
about sensitive bodily areas), were identified as main barriers to seeking help for symptoms 
of various cancer types [9]. Like the other reviews, this review only identified emotions 
labelled as fear as playing a role in TTP with symptoms of cancer, but does show the 
potential relevance of other emotions (e.g. embarrassment). 
Previous literature reviews have not explored the contradictory role of fear or the role of 
other emotions on TTP. The inclusion of qualitative studies in the previous reviews limits the 
generalisation of conclusions regarding the impact of emotions on TTP. Furthermore, there 
has been little exploration of similarities and differences between populations and cancers. 
The aim of this systematic literature review was to examine the worldwide quantitative 
literature to explore how emotional factors influence patients’ help-seeking for symptoms 
possibly suggestive of cancer. We were particularly interested in how, and to what extent, 
emotions contribute to TTP. The objectives were to identify: (1) which types of emotions 
influence help-seeking behaviour; (2) whether these form a barrier or trigger for seeking 
medical help; and (3) how the role of emotions varies between different cancers and 
populations.  
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METHODS 
We systematically searched the databases PubMed, PsychINFO, IBSS and ASSIA up to 30
th
 
September 2013, with no earliest year of publication or language restrictions. Reference lists 
of all included papers were searched, and all lead authors from publications after 2000 were 
contacted for further research findings (of which the latter did not lead to any further relevant 
papers). Search terms were focused on four main themes: emotion(s), help-seeking, cancer 
and symptoms, see Figure 1. There is a surprisingly broad range of definitions of what 
constitutes an emotion [21]. For this review we considered the following definition the most 
relevant: emotion is a ‘response to a certain event, which can be external or internal to the 
individual’ [14]. We have only considered patients’ subjective experiences of emotion as 
relevant (omitting facial expressions and physiological changes [22]). The search terms for 
emotion included synonyms for emotion as well as a wide range of emotions, and we selected 
emotions for inclusion based on emotions listed in Scherer’s affect categories [22].  These 
categories were based on emotions reported by people who were asked which emotions they 
had experienced the day before, as well as emotions measured in published emotion measures 
and included positive as well as negative emotions [22]. An example of an affect category is 
anxiety, which included ‘anguish*, anxi*, apprehens*, diffiden*, jitter*, nervous*, trepida*, 
wari*, wary, worried*, worry*’. We included relevant emotions after reaching mutual 
consensus on inclusion between the authors, and we validated our selection with an 
international expert on early detection of cancer. We differentiated between emotion 
constructs (e.g. fear, anxiety and worry as separate constructs) to be able to explore their 
individual impact on help-seeking, and looked at a wider range of emotions and at specific 
emotions. We included original research papers published in peer-reviewed journals, which 
examined any emotion specific to symptom appraisal or help-seeking for symptoms of cancer 
(all types) or symptoms potentially indicative of cancer. Manuscripts were excluded if they 
were non peer-reviewed, conference abstracts, reviews, or reported studies with participants 
previously diagnosed with the same type of cancer, studies on screening, or set among non-
symptomatic individuals. 
*** Insert Figure 1 about here (or as supplementary file online)*** 
Data extraction was undertaken by all authors. Extracted data included demographics of the 
study sample, the definitions of included emotion and TTP, and data related to TTP. We also 
extracted data concerning whether the emotion was a barrier or a trigger, and how the 
emotion affected TTP. We chose to use a descriptive, narrative approach [23] to synthesise 
the papers because of the heterogeneity of study methods. For instance, there was a lack of 
definition or consistent use of emotion terms (for example fear was ‘fear of treatment’ in one 
study and ‘fear of cancer’ in another). 
 
Quality assessment 
Each author used the Dixon-Woods criteria to rate the overall relevance of each included  
paper as: Key Paper, Satisfactory paper, Unsure, Fatally Flawed (indicating mistakes or 
contradictions in results), and Irrelevant [24]. This approach was chosen based on Malpass et 
al’s recent critique of approaches to quality assessment [25].’Key’ and ‘Satisfactory’ papers 
were included. ‘Unsure’ papers were discussed until we reached agreement, and papers 
judged ‘Fatally Flawed’ and ‘Irrelevant’ were excluded, as it was not possible to make valid 
or relevant conclusions from these papers. This assessment of the relevance of the data on 
emotion and TTP in the paper was important in our review. Rather than focusing solely on 
the overall quality of the paper using the guidelines such as the Critical Appraisal Skills 
Programme (CASP) [26, 27], we chose to be inclusive, to be able to thoroughly review all the 
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data available on emotions and TTP, and to explore methodological issues to address the 
limitations in the studies.  
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RESULTS 
 
From the initial 13,191 unique abstracts identified via the systematic search, 33 papers were 
included in the review (see Figure 2 for the PRISMA flow diagram). One paper was 
excluded based on the Dixon-Woods criteria (fatally flawed) as results in text and tables were 
contradictory [28], and two included papers were rated as a key paper as their results were 
highly relevant [29, 30]; the remaining studies were considered to be satisfactory.  
 
***Insert Figure 2 about here*** 
Study and participant characteristics 
Details of the 33 included papers can be found in Table 1. The sample size of the studies 
ranged from 48 [31] to 2154 [32]. Twelve studies conducted the emotion analyses on only 
part of their sample
1
 [15, 16, 30, 33-41], usually on the group with long TTP (except for one 
study which only reported emotion data from the participants aged 35 years and older 
[39]).The majority of studies were set in the United Kingdom (n=9) or United States (n=9). 
Most studies (n=24) were conducted among individuals with breast symptoms [16, 17, 29-32, 
34-39, 42-53], two studies were among patients with colorectal cancer symptoms [54, 55], 
three studies reported data from a variety of cancer types [15, 40, 56], while there were a 
single report each concerning uterine cancer [57], prostate cancer [33], melanoma [58] and 
penile cancer [41]. The majority of studies recruited diagnosed cancer patients [15, 16, 31-33, 
36, 37, 40-46, 49, 51, 52, 55-58], ranging from immediately [49]  to several years after 
diagnosis [42, 58]. Eleven studies were conducted among symptomatic individuals prior to 
diagnosis [17, 29, 30, 34, 35, 39, 47, 48, 50, 53, 54]: in six of these papers the cancer 
diagnoses of these individuals became available after data collection [29, 30, 35, 39, 47, 50]. 
As most studies reported symptoms of breast cancer, their samples were exclusively female; 
studies on other cancer types included both males and females (except for the studies on 
uterine [57], prostate [33] and penile cancers [41]. The mean age in the studies ranged from 
37.5 years [17] to 77.6 years [43]. Ten studies reported a mix of two or more ethnicities [17, 
29, 33, 37, 39, 45, 47, 48, 54, 57], whereas three studies specifically looked on differences in 
emotions and TTP between two ethnicities [33, 45, 57]. Two predominantly focused their 
study on one ethnicity (African American) [31, 42] and the other studies did not report 
specifically on ethnicity. 
 
***Insert Table 1 about here*** 
Methodology of studies 
Only one study [42] clearly stated that identifying the role of emotion (worry) was a study 
aim, and in another study the authors specifically stated hypotheses about the role of 
emotions in TTP [30]. Most studies aimed to identify the TTP and/or factors related to TTP 
without specifying the role or range of emotions. Sixteen papers reported solely descriptive 
data, while uni- or multivariate data were reported in 16 papers [17, 29-31, 42-45, 47-50, 54, 
55, 57, 58] (see Table 5 for a summary). There were two main strategies for measuring 
emotions. Either qualitative data was collected from participants through open questions, 
                                                          
1
 The number of participants included in the emotion analysis is displayed in italics in the column ‘sample size’ 
of Table 1 
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which were then quantified and grouped into an emotion category as defined by the 
researcher, or the selection of a certain emotion was decided prior to the study and measured 
using a questionnaire. Meechan and colleagues [29] developed a four-item measure for 
emotional responses to a cancer symptom. Two other studies [48, 49] used an adapted version 
of this measure.  
In measuring TTP, 19 studies adopted cut-off points indicating ‘long TTP’, which ranged 
from one week to three months. The most common cut-off was three months, but in ten 
papers authors used a different approach [16, 33, 36, 37, 39, 46-48, 54, 59]. Five studies 
measured TTP as a continuous variable [31, 42, 45, 57, 58]. 
Range and types of emotions reported in the studies 
None of the studies provided definitions of the emotions that they reported, and some used 
emotion terms interchangeably, for instance, in three studies worry was used interchangeably 
with concern [17, 45, 57]. Twenty-six studies studied fear (or closely related emotions such 
as being scared, afraid or having had a frightening experience) in relation to TTP, see Table 
2 [15-17, 29-35, 37-41, 43, 44, 46-48, 50-53, 55, 56], while worry (or closely related 
emotions such as concern) was reported in ten studies (see Table 3) [17, 34, 36, 42, 45, 48, 
50, 54, 57, 58]. Three studies reported embarrassment [34, 41, 56], one reported shame [51], 
another studied distress, depression and anger [48], and three studies reported general 
emotional response to the discovery of a symptom (see Table 4) [29, 48, 49].  
 
Non-specific and specific emotions  
Some studies reported non-specific emotions, that is, emotions without details of the context 
or reason for this emotion, such as fear [16, 17, 31, 33, 34, 39, 51], or embarrassment [34, 
41]. In other studies more detailed information about the emotion was given, being more 
specific about the reason for the emotion. These ‘specific emotions’ (as previously defined by 
Facione [20]) varied greatly between studies (see Tables 2-4).  
 
***Insert Tables 2-5 about here (or as supplementary file online) *** 
 
The impact of emotions on TTP 
 
Fear (see Table 2) 
The proportion of patients who cited fear as a reason for not presenting earlier was generally 
low (below 30%), with the exception of 3 studies on breast cancer: Scared
2
 of financial costs 
(75%) in a study in Egypt [38], non-specific fear (44%) in a study in the UK [34], and Fear 
of mastectomy (45%) in a study in Nigeria [32]. In the majority of studies, fear was only 
studied among patients with long TTP and some studies only reported the proportion of 
patients of the whole sample who cited fear. 
Three studies [17, 39, 41, 56] descriptively compared the proportion of patients who cited 
fear as a barrier or trigger between those with long versus short TTP. However, the number of 
patients involved in these descriptive comparisons was extremely low (maximum n=12 [39]) 
making conclusive interpretation difficult. Ten studies [17, 29-31, 43, 44, 47, 50, 53, 55] 
explored levels of fear in relation to TTP using uni/multivariate statistics. One study reported 
that levels of non-specific fear were not significantly associated with TTP [31]. Fear on 
                                                          
2
 In the abstract of the paper scared was used interchangeably with fear, and therefore included in the section on 
fear 
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discovery of symptoms was found to be unrelated to TTP in three studies [43, 44, 48], 
whereas a fourth study reported fear on discovery of symptoms was associated with shorter 
TTP in patients with benign disease but not those diagnosed with cancer [30]. This study also 
found fear on discovery of symptoms to be related to shorter ‘appraisal delay’ for those with 
benign disease and shorter ‘utilisation delay’, which is the same as the help-seeking interval 
[60]’, for those diagnosed with cancer. 
With regard to specific fears, there were mixed results. Fears about diagnosis [55], cancer 
[17], or disease [53]  were found to be unrelated to TTP, with the exception of one study [47] 
that reported fear of cancer diagnosis to be associated with longer TTP. Li et al [30] reported 
that fear of implications (possibly cancer) was associated with longer ‘utilisation delay’ (but 
not TTP) for those diagnosed with cancer (but not those with benign disease). 
Burgess et al [43] found women who had longer TTP were more fearful of the consequences 
of diagnosis or medical treatment of cancer, yet in three studies fears about treatment or 
consequences (e.g. dying, breast loss) were reported to be unrelated to TTP [29, 50, 53]. 
 
Worry (see Table 3) 
One study on breast cancer reported being too worried to approach the GP as a barrier to 
presentation, although this was only reported by 3% of those with long TTP [36]. In contrast, 
worry about cancer [17] and non-specific anxiety [50] were cited as reasons for consultation, 
and having nothing to worry about was a reason for later presentation in 9-43.9% (n=25) of 
those with long TTP [34, 36]. 
In descriptive comparisons, worry or anxiety about symptoms was reported more often by 
those with short TTP (44-85%) compared to those with long TTP (15-34%) [48, 50, 54]. This 
was supported in univariate comparisons in five studies [45, 48, 50, 54, 57], where worry or 
anxiety about symptoms was reported to be associated with shorter TTP, but was unrelated to 
TTP in two studies [42, 58]. Worry about breast cancer diagnosis was only investigated by 
one study, which found no association with TTP [42]. 
 
Other emotions (see Table 4) 
Being embarrassed at being examined by a doctor was reported as a reason for later 
presentation by 13% of British patients with breast symptoms with long TTP (> 3 months), 
whereas none of the patients with short TTP reported this barrier [56]. Non-specific 
embarrassment was a cited as a reason for not presenting earlier for 4% of those with short 
TTP and 16-25% of those with long TTP (or those who were ‘reluctant’ to see a doctor) [34, 
41]. No papers used uni/multivariate statistics to study the impact of embarrassment on TTP. 
Shame was a reason for later presentation for only 4.5% of the total sample in a study of 
breast cancer among Libyan women [51] but this was not investigated in relation to TTP. In a 
study on breast cancer in Ireland, levels of distress, depression, and anger on discovery of 
breast symptoms were found to be low (reported by less than 20% of patients) and were 
unrelated to TTP [48]. 
Two studies looked at a general emotional response to symptom discovery that consisted of 
the combined level of a range of non-specific emotions (e.g. afraid, anxious, distress, scared, 
concerned) in response to either discovering symptoms of breast cancer [29] or potentially 
malignant oral symptoms [49]. This general emotional response to symptom discovery was 
not associated with TTP in the study on oral cancer [49] but higher emotional response was 
associated with shorter TTP in in the study on breast cancer [29]. However, when the levels 
of emotional response were compared between those who sought help promptly (<3 months) 
and those who waited (> 3months) no significant differences were found. 
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The role of emotions between different cancers and populations 
Some emotions were only reported in certain countries, for example, scared of the financial 
cost of malignant disease and its consequences was only reported in an Egyptian study [38]. 
Other emotions were more widespread. For instance, fear about breast cancer treatment (e.g. 
operations, mastectomy and/or disfigurement) was reported in studies from the UK [35, 43, 
50, 56], Pakistan [46], Nigeria [32, 52], Germany [37], New Zealand [29] and Australia [53]. 
There appeared to be no differences for the role of emotions in TTP between age groups. For 
instance, the results from a study among elderly women [43] corroborated with the findings 
from a similar study set among younger women [44]. One study specifically investigated 
significant differences in reporting of being afraid of diagnosis as a barrier between the age 
groups <60, 60-74 and 75+, and found no significant differences [55]. No studies reported 
differences between sexes. No differences were found between the findings from pre- and 
post-diagnosis studies. 
Differences between cancer types were rarely explored within the studies as only 3 of the 33 
papers studied more than one cancer type. Mor [40] reported the percentages of participants 
that gave fear of discovering the cause of their symptoms as their reason for later presentation 
specifically for breast (20.7%), lung (10.5%) and colorectal cancer (16.9%), but did not 
compare the cancer types using statistical tests. Coates and colleagues tested the association 
of worry / concern with TTP in patients diagnosed with breast cancer [45] and uterus cancer 
[57]. In both studies worry and thinking it was serious was associated with timely 
consultation, however worry and thinking it was cancer was only associated with short TTP 
among the breast cancer patients [45]. 
There were no differences between ethnicities in Coates et al.’s studies [45, 57], but Talcott 
reported that fear was more often a reason to present late with prostate symptoms for African 
American men (11.1%) compared to Caucasian men (7.4%, p<0.01) [33]. 
Comparing cancer and non-cancer patients, fear of a cancer diagnosis was more often a 
reason for later presentation for patients who received a cancer diagnosis (11.5%) than 
patients whose diagnosis was benign (4%), including when only individuals with long TTP 
were considered (cancer 22.2% vs non-cancer 5.1%, X
2
 = 10.8, p=.001) [47]. In a 
multivariate analysis by Li et al. [30] low fear on symptom discovery was related to longer 
appraisal interval and total TTP in the benign sample but not in the cancer sample. In 
contrast, low fear on symptom discovery and high fear of implications (possibly cancer) was 
related to a longer utilisation interval in the cancer sample, but not the benign sample [30]. 
 
 
  
 10 
CONCLUSIONS 
Principal findings 
This is the first systematic literature review of quantitative evidence examining the role of a 
wide range of emotions in TTP for potential cancer symptoms. The review provides some – 
seemingly contradictory - evidence for a role for emotions in TTP. A key finding was that 
few studies had their main focus on emotions. Furthermore, there are several methodological 
and conceptual limitations, which limit the interpretation of the existing literature. 
Nevertheless, we believe that the findings provide some evidence for the impact of a range of 
non-specific and specific emotions on TTP for symptoms suggestive of cancer.  
Although we purposely looked for a wide range of emotions, we only found studies reporting 
a limited range of emotions, mainly related to fear and worry. Whilst these emotions may 
have been chosen for investigation because of their known and anticipated impact on 
individuals’ help-seeking decisions, this does not necessarily reflect the actual range and 
importance of emotions that affect peoples’ decisions to seek help. Other emotions could be 
important too: three studies indicated embarrassment may be a reason for long TTP, but at 
present only descriptive quantitative data (and some qualitative data [9, 61, 62]) exist. There 
are other emotions such as guilt [63] that may play a role in help-seeking for symptoms but 
have not been studied quantitatively in this context.  
The impact of emotions appears mixed, sometimes acting as a barrier to consultation whilst at 
other times being a trigger to presentation or being unrelated to TTP. Consideration of 
theoretical explanations of help-seeking behaviour may help to explain these inconclusive 
findings. The Model of Pathways to Treatment described by Walter and colleagues is a 
framework based on Safer et al.’s (1979) and Andersen et al.’s (1995) Model of Total Patient 
Delay [5, 64] that identifies different intervals, events, processes and contributing factors 
within TTP and beyond) [60]. The ‘Appraisal Interval’ is the ‘time from detection of a bodily 
change to perceiving a reason to discuss symptoms with a Health Care Practitioner (HCP)’ 
and the ‘Help-seeking Interval’ is the ‘time from perceiving a reason to discuss symptoms 
with a HCP to the first consultation with a HCP about their symptoms’ [59]. Only one study 
[30] in the review deliberately divided between two intervals of TTP (‘appraisal delay’ and 
‘utilisation delay’, which are roughly equivalent to the appraisal and help-seeking interval). 
This study indicated that higher fear on symptom discovery was associated with shorter 
appraisal delay (for the benign sample, but not for the cancer sample) and shorter utilisation 
delay (in the cancer sample, but not in the benign sample). A different specific fear (fear of 
implications of the possibility of cancer) was associated with a longer utilisation delay but 
unrelated to appraisal delay. This indicates that it is plausible that different emotions could 
play different roles at different times prior to presentation with a HCP. It also shows the 
importance of taking possible differences in the role of emotions in TTP between populations 
and contexts into account. 
Although none of the other studies measured emotions specifically associated within the 
appraisal interval or help-seeking interval per se, a number of studies reported emotions about 
symptoms or in response to the discovery of symptoms. Generally, worry or anxiety about or 
upon discovering symptoms was reported to be a reason for consulting a HCP, and was 
associated with shorter TTP.  Fear on discovery of symptoms appeared to have contradictory 
impact: some studies found no effect whereas others reported this emotion to be associated 
with shorter TTP.  
Regarding the help-seeking interval, fears that were about seeking help, diagnosis, treatment 
and its consequences were generally barriers to seeking help [43, 47] prolonging TTP, or did 
not have a relationship with TTP [29, 42, 50, 53, 55]. The Model of Pathways to Treatment 
provides a theoretical framework to underpin and explain how different non-specific and 
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specific emotions play a role across different stages of the TTP [59, 60] Future research could 
purposefully apply this model to test this hypothesis 
Strengths and limitations of the review 
Strengths of our review were the systematic search of literature including a wide range of 
emotions and that initially identified 13,180 papers in four databases, and rigorous data 
extraction conducted by three authors from complementary disciplines (medicine, psychology 
and social science). We could not perform a meta-analysis of the study results, as there was a 
lack of consensus on emotion definitions and study methods. Meta-analysis could have 
provided more insights into the actual impact of emotions on TTP, and could have provided 
information on the size of the effect of emotions in TTP. However, a descriptive synthesis of 
the heterogeneous studies allowed exploration of the possibility of different effects of 
different specific emotions on TTP.  
 
Methodological issues in existing research 
We have identified various methodological limitations of the included studies. Firstly, very 
few of the studies had emotion as the main focus of the research. In fact, only two studies 
stated the aim to explore the relationship between emotion and TTP, Bradley [42] and Li, 
Lam [30] formulated specific hypotheses.  
Secondly, there was little homogeneity in the way emotions were defined and measured in 
the studies. This makes it difficult to evaluate their construct validity and to compare 
seemingly similar emotions between studies. The conflicting results around the role of 
emotions on TTP may be due to the lack of definition of each specific emotion. Closely 
related to this is that none of the studies have used validated questionnaires – an issue 
considered important in researching TTP according to the Aarhus statement [6]. This means 
that it is not possible to know if the emotions measured were actually reflecting these specific 
emotions, and to which extent the results were comparable across studies.  
Thirdly, studies tended to explore ‘reasons for later presentation’ rather than focusing on 
exploring all possible directions of the relationship between TTP and emotion [65]. This 
aspect of study design led many studies to only study emotions in those who waited prior to 
seeking help, omitting the potential role of emotions in reducing TTP. 
Furthermore, as with all research into help-seeking the majority of the studies are 
retrospective, with some studies including patients who had been diagnosed with cancer for 
many months or years. It is likely that this may have biased their recall of emotions during 
the TTP with their symptoms. This recall bias may also differ between patients diagnosed 
with cancer and people who were still awaiting their diagnosis at the time they participated in 
the study, or those diagnosed with a benign condition.  
Finally, few studies focused on the = size of the impact of the emotion(s) on TTP, and with 
the current knowledge in this review, we cannot be sure how important it is to look at the role 
of patients’ emotions in help-seeking decisions: a difference in TTP of 1 day is likely not to 
be clinically relevant, but a difference of 2 weeks or more might be. 
Implications  
There is a need for further well-designed studies guided by the Aarhus statement [6], 
including clear definitions of specific emotions as well as non-specific emotions to identify 
the patient groups at risk for later presentation and the impact of emotions which may 
increase or decrease this risk. This may help in the development of relevant interventions 
targeting these patient groups and specific emotions, and emotions associated with symptom 
appraisal or help-seeking and its consequences. Exploring the link between cognitions and 
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emotions as suggested in the Common-Sense Model by Leventhal [13] could unpack the role 
of emotions in symptom appraisal, and more specifically the concept of symptoms being 
‘worrisome’. Qualitative studies could also improve our understanding of why, and under 
which circumstances, emotions play a role in people’s decisions to seek help for symptoms 
suggestive of cancer. 
It will also be important to take differences between populations, settings, cancers and 
symptoms into account in future studies. For example, fear of treatment may have a more 
negative impact on TTP if the treatment is perceived as particularly harmful, for example in a 
country where radical mastectomy is the most common treatment for breast cancer compared 
with a lumpectomy as the most common choice in other countries. As the majority of the 
studies in this review researched breast cancer, future research could also include other 
cancer types which are equally common among the population and causing higher mortality, 
such as colorectal cancer and lung cancer [66].  
 
Conclusion 
This systematic review provides some quantitative evidence for the role of emotions as 
barriers as well as triggers in TTP, and suggests a role for a wider range of emotions 
including specific emotions. However, it also highlighted widespread methodological, 
definition and design issues among the included papers, therefore more quantitative well-
designed research is needed to be able to draw stronger conclusions on the different roles of 
specific emotions in the pathway to presentation for potential cancer symptoms.  
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Table 1: Characteristics of included studies 
                                                          
3
 Interview = quantified interview data 
4
 The term ‘delay’ is used in the tables if used in study aims by the reported study 
Studies Participants Data collection Aims 
Author & 
year 
Country Cancer 
type 
Sample size 
(C: cancers) 
(E: emotion 
analyses) 
Gender (% 
Female) 
Age: 
mean 
(SD) 
Range 
Method Timing 
 
To identify… 
Pre 
diagnosis 
Post 
diagnosis 
Adam  
1980  
[36] 
UK Breast n=162 
(C:162) 
(E: 66) 
100%  - Interview3   (at 
treatment) 
 
Not stated 
Ajekigbe  
1991 
[32] 
Nigeria Breast n=2154 
(C:2154) 
(E:2154) 
100% - Self-administered 
survey 
  Reasons for lateness in presenting suspicious breast lumps for 
diagnosis and treatment 
Arndt  
2002  
[37] 
Germany Breast n=287 
(C:287) 
(E: 103) 
100% 57.3 Interview-
administered survey 
 (50% 3 
weeks; 90%  8 
weeks)
Extent, nature and length of duration of symptoms; Factors 
related to longer TTP; Association of patient delay4 and stage 
at diagnosis 
Bhosai  
2011  
[15] 
Thailand Various n=264 
(C:264) 
(E: 75) 
68.3% - Self-administered 
survey 
  Patient and healthcare factors in patient delay 
Bradley  
2005  
[42] 
US Breast n=60  
(C:60) 
(E: 60) 
100% 49.3 
(9.9) 
24-75 
Interview-
administered survey 
 (2-348 
months) 
Delay and worry experiences; Relationship between delay and 
worry; Relationship between delay, demographic and illness-
related factors 
Brochez  
2001  
[58] 
Belgium Cutaneous 
melanoma 
n=130 
(C:130) 
(E:130) 
68% 53   
18-89 
Interview-
administered survey 
 (1-52 
months 
Diagnostic pathway; Patient and physician delay; Definition of 
factors related to delay 
Burgess  
1998  
[44] 
UK Breast n=185 
(C:185) 
(E: 175) 
100% 54 Interview   (+/- 8 weeks 
at treatment) 
Patient and GP delay;  Contribution of tumour-related and 
psychological factors to each phase of delay  
Burgess  
2006  
[43] 
UK Breast n=69  
(C:69)  
(E: 69) 
100% 77.6 (8) 
65-96 
Interview   (4-8 weeks at 
follow up)  
Whether risk factors for delayed presentation apply in older 
women 
Cameron 
1968 
[50] 
UK Breast n=83 
(C:57) 
(E:83) 
100% - Self-administered 
survey 
  Relation between aspects of mammary tumour, patients’ 
personalities or social background and delay in consultation 
with a breast lump 
Coates  
1992  
[45] 
US Breast n=735 
(C:735) 
(E: 735) 
100% - Interview   (65% 3 
months; 87% 6 
months) 
Differences between black and white women in extent of delay; 
Extent to which other factors associated with length of delay 
may explain racial differences 
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Coates  
1998  
[57] 
US Uterus n=331 
(C:331) 
(E: 331) 
100% - Interview   (Median: 89 
days black; 82 
days white) 
Differences between black and white patients in their TTP; 
Extent to which differences in consultation rates might 
contribute to racial differences in stage 
Elzawawy 
1999  
[38] 
Egypt Breast n=182 
(C:182) 
(E: 78) 
100% 43.8  
19-76 
Interview   (Up to 6 
months) 
Not stated 
Ermiah 
2012 
[51] 
Libya Breast N=200 
(C:200) 
(E: 200) 
 
100% 45.4 
22-75 
Interview  (22.5% 
within 4 weeks; 
77.5% within 8 
weeks) 
Extent and reasons behind diagnosis delay of breast cancer 
Greer  
1974  
[35] 
UK Breast n=157  
(C:69) 
(E: 40) 
100% - Interview   Factors related to delay in help seeking 
Harirchi  
2005  
[16] 
Iran Breast n=200 
(C:200) 
(E: 132) 
100% 46.8 
20-79 
Interview-
administered survey 
 
  Extent and determinants of patient delay 
 
 
Hashim  
2010  
[54] 
Malaysia Colorectal n=80  
(C: unknown) 
(E: 80) 
43.8% 61.1 
41-86 
Self-administered 
survey 
  Proportions of patients with rectal bleeding who delayed in 
seeking medical advice; Factors associated with delay 
Henderso
n 1966  
[56] 
UK Various n=50  
(C:50) 
(E: 50) 
96% 26-76 Interview-
administered survey 
 (After 
treatment) 
 
Not stated 
Ibrahim 
2012 
[52] 
Nigeria Breast n=201 
(C:201) 
(E:201) 
100% 49.8 
(13.6) 
23-104 
Interview 
administered survey 
  Influence of socio-demographic factors on late presentation; 
The reasons for delayed reporting of breast cancer patients 
Lauver  
1995 [17] 
 
US Breast n=138  
(C: unknown) 
(E: 138) 
100% 37.5 
19-76 
Interview   Factors that influenced women with breast changes to seek 
care; Women’s difficulties in seeking care for breast changes  
 
Li 
2012 
[30] 
 
Hong 
Kong 
Breast n=425 
(C: 135) 
(E: 87/425) 
100% 51.97 
(12.8) 
29-90 
Interview-
administered survey 
  Appraisal, Utilization, and Total Delay and variables associated 
with each; Hypotheses specifically on emotion:  
-Appraisal Delay is a product of symptom interpretation, 
emotional response, and disclosure of symptoms to others 
-Symptom presentation, symptom attribution, and emotional 
responses to symptoms are interrelated  
 
Magarey 
1977 
[53] 
Australia Breast n=53 
(C:unknown) 
(E:53) 
100% - Self-administered 
survey and coded 
video 
 (At least 
a day 
before 
biopsy) 
 A rational basis for cancer education and management of 
patients with cancer symptoms 
Malik  
2003  
[46] 
Pakistan Breast n=138 
(C:138) 
(E: 138) 
100% 46.1 Interview-
administered survey 
 (up to 3 
months) 
Perceptions of patients regarding breast lump; Frequency and 
reasons for delay; The influence of the practice of CAM to treat 
symptoms on clinico-pathological characteristics of the disease 
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Meechan  
2003  
[29] 
New 
Zealand 
Breast tn=85  
(C:7)  
(E: 85) 
100% 38.9 
(1.5) 
20-71 
Interview  
 
Self-administered 
survey 
  Association between delay and type of breast symptom, initial 
emotional response to the symptom, perceived risk of breast 
cancer, role of talking to others about symptoms, demographic 
and clinical factors 
Mor 
1990 
[40] 
 
 
US Lung 
Breast 
Colorectal 
n=625 
(C: 625) 
(E:123) 
Lung: 33.9% 
Breast: 100% 
Colorectal: 47% 
45-90 
 
Interview   (‘newly 
diagnosed’; 
average after 11 
wks) 
Relationship between socio demographic and disease related 
variables with cancer patients’ recognition of symptoms 
diagnosis and subsequent delay; Patients’ reasoning regarding 
symptom experiences to understand the role of gratitude and 
misconception in patient delay 
Nichols  
1983  
[34] 
UK Breast n=1175  
(C: unknown) 
(E: 400) 
100% - Interview  
Interview-
administered survey 
  Reluctance to, and reasons as to why patients see a doctor 
about breast symptoms  
Nosarti  
2000  
[47] 
UK Breast n=692  
(C:62)  
(E: 692) 
100% 51.8 
(9.8) 
40-75 
Interview  
Interview-
administered survey 
  Risk factors for women who tend to have long delays  
O’Mahon
y 2009  
[48] 
Ireland Breast n=99  
(C: unknown) 
(E: 99) 
100% 40 
(11.8) 
18-75 
Self-administered 
survey 
  Extent of delay; Factors influencing women seeking help from 
a HCP on self-discovery of a breast symptom  
Prohaska 
1990 
[55] 
US Colorectal n=254 
(C:254) 
(E: 254) 
52% 67.0 
31-89 
Interviews  (Within 6 
months) 
Symptom perceptions and illness behaviours prior to cancer 
diagnosis to determine age patterns and effect in self-care 
activities 
Reifenstei
n 2007  
[31] 
US Breast n=48  
(C:7) 
(E: 48) 
100%  40 (9.5) 
22-64 
Self-administered 
survey 
 (Less than 1 
yr since 
symptoms) 
Relationship between fear, denial, utility, social norm, and 
delay in care seeking; Relationship between having a health 
provider, accessible healthcare services, and delay; Whether the 
effect of fear on delay was mediated by denial;  Whether the 
effect of social norm on delay was moderated by utility; 
Relationship between denial and escape-avoidance coping 
Skeppner 
2012 
[41] 
Sweden Penile n=59 
(C:59) 
(E: 48) 
 
0% 37-73 
 
Interview-
administered survey 
  Insight into patients’ perception of initial symptoms and factors 
associated with patients’ delay; Whether and to what extent 
there is doctors’ delay; Whether tumour stage is associated 
with delay 
Sugar  
1961  
[39] 
US Breast n=50 
(C:11) 
(E: 26) 
100% - Interview    - 
 
 
Scott  
2008  
[49] 
UK Oral n=80  
(C:67) 
(E: 80) 
70% 53 
(15.2) 
Self-administered 
survey 
  (directly after 
diagnosis) 
Theoretically guided insight into patient delay; Clinical factors, 
patient socio-demographics, and health-related behaviours not 
related to patient delay  
 
Talcott  
2007  
[33] 
US Prostate n=555 
(C:555)  
(E: 39)  
0% 40-75 Interview-
administered survey 
 (Aim before 
treatment (often 
not)) 
Range of potential explanatory factors that might account for 
racial disparity (socio-demographic factors, access to care, 
attitudes and beliefs regarding prostate cancer screening and 
diagnosis, and trust in physicians) 
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Table 2: Impact of ‘fear’ on TTP 
 
Author & 
year 
Definitions Results 
Cut-off point 
long TTP 
Specific fear5 Descriptive results 
 
Uni- or multivariate results 
Reported as reason for... Short TTP % (n) Long TTP % (n) Total sample % 
(n) 
Sugar  
1961  
[39] 
> 1 week  
(n=27) 
Fear of cancer consultation by: 30% (7) 31% (5) - - 
6 
 Fear consultation by: 4% (1) 0% (0) - 
Talcott  
2007  
[33] 
> 3 weeks 
(n=39) 
 
Fear not presenting earlier by: - 9.3% (4) - - 
Arndt  
2002  
[37] 
> 1 month 
(n=103) 
 
Fear of diagnostics, surgery not presenting earlier by: - 8.7% (9) - - 
Harirchi  
2005  
[16] 
> 1 month  
(n=136) 
 
Fear not presenting earlier by: - 18.4% (25) - - 
Malik  
2003  
[46] 
>1 month  
(n=73) 
Fear of surgery, mastectomy not presenting earlier by: - - 22% (30) - 
 
Fear of cancer not presenting earlier by: - - 6% (8) 
Bhosai  
2011  
[15] 
> 3 months 
(n=75) 
 
Fear of seeking treatment not presenting earlier by: - 34.7% (26) - - 
Mor 
1990 
[40] 
> 3 months 
(n=123) 
Fear of discovering the cause of 
their symptoms 
not presenting earlier by: - 16.8% (14) 
[20.7% breast7 
10.5% lung  
16.9% colorectal] 
- - 
Skeppner 
2012 
[41] 
Four groups: 
 < 3 months; 3-6 
months; 6-12 
months; >1 year  
Fear of severe disease not presenting earlier by: < 3 months: 0% (0) 
3-6 months: 0% (0) 
 
6-12 months: 2.08% (1) 
>1 year: 2.08% (1) 
 
 
- - 
 
Ajekigbe 
1991 
[32] 
 
No cut-off Fear of mastectomy not presenting earlier by: - - 44.7% (963) - 
                                                          
5 ‘Fear’ indicates that the study only reported a non-specific fear 
6 ‘-‘ indicates uni- or multivariate results were not available in the study.  
7 n presenting late for each cancer group was not given 
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Ermiah 
2012 [51] 
No cut-off Fear not presenting earlier by: - - 10% (20) - 
Elzawawy 
1999  
[38] 
>3 months (n=78) Scared of the financial cost 
malignant disease and its 
consequences 
not presenting earlier by: - 75% (59) - - 
Greer  
1974  
[35] 
> 3 months 
(n=40) 
Fear of diagnosis not presenting earlier by: - 25% (10)  - - 
Fear of disfigurement / mastectomy not presenting earlier by: - 17.5% (7) - 
Fear of hospitals / anaesthesia / 
surgery 
not presenting earlier by: 
 
- 5% (2) - 
Henderson 
1966  
[56] 
 >3 months 
(n=38);  
 
Frightening experience with 
patients who died of cancer 
not presenting earlier by: 
 
16.6% (2) 7.9% (3)  - - 
 
 Fear of doctors not presenting earlier by: 0% (0) 10.5% (4) - 
Fear of hospitals not presenting earlier by: 0% (0) 13.1% (5) - 
Fear of operations not presenting earlier by: 0% (0) 10.5% (4) - 
Fear of dying not presenting earlier by: 8.3% (1) 2.6% (1) - 
Fear of what will be told not presenting earlier by: 0% (0) 21% (8) - 
Ibrahim 
2012 
[52] 
> 3 months Fear of mastectomy not presenting earlier by: - - 29.3% (48) - 
Nichols 
1983  
[34] 
Medium 4-12; 
long >12 (not 
used in results) 
Fear not presenting earlier by: - 44% 8 - - 
 
Prohaska 
1990 
[55] 
No cut-off Afraid of diagnosis not presenting earlier by: - - 18% (44) Afraid of diagnosis was not significantly 
associated with delay (r=0.04, n.s.) 
 
Lauver  
1995 [17] 
 
> 3 months 
(n=32) 
Fear about cancer not presenting earlier by: 
 
- - 5.3% of total 
responses 
There was no significant difference in the 
proportion reporting fear as a barrier 
between the those with short and long 
TTP (statistical information not given) 
Reifenstein 
2007  
[31] 
 No cut-off  Fear - - - - There was no significant association 
between fear and TTP (r=-0.3, p-value 
not given) 
 
 
 
 
                                                          
8 Of the ‘reluctant’ group. Being reluctant was associated with with longer TTP (p<0.005). 
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Li 
2012 
[30] 
Appraisal: > 60 
days;  
Utilisation: > 14 
days;  
Total: > 90 days 
Scared / Fear on symptom 
discovery 
not presenting earlier by: - 6.8% (6) 
(of those with appraisal 
interval > 1 week) 
- A low fear on discovery was related to: 
longer appraisal interval (whole sample: 
X²(1)=18.116, p<0.001; benign sample: 
OR 6.28, 95% CI 1.88-21.03, p<0.05; 
cancer sample=n.s.); longer utilisation 
interval (whole sample: X²(1)=10.458, 
p<0.05; cancer sample: OR 43.11, 95% 
CI 3.39-548.20, p<0.05; benign 
sample=n.s.); longer total TTP (benign 
sample (OR 3.03, 95% CI 1.14-8.09, 
p<0.05; cancer sample=n.s.). 
Fear of implications (possibly 
cancer) 
 
not presenting earlier by: - 8.2% (7) 
(of those with utilisation 
interval > 14 days) 
 
- High fear of implications (possibly 
cancer) predicted longer utilisation 
interval (cancer sample: OR 3.56, 95% CI 
1.16-10.97, p<0.05; benign sample=n.s.). 
Magarey 
1977 
[53] 
No cut-off Conscious fear of dying - - - - There was no relationship between TTP 
and conscious fear of dying (r=0.018, 
p<0.059) 
Conscious fear of breast loss - - - - There was no relationship between TTP 
and conscious fear of breast loss 
(r=0.032, p>0.05) 
Conscious fear of disease - - - - There was no relationship between TTP 
and conscious fear of disease (r=0.135, 
p<0.05). 
Meechan 
2003  
[29] 
> 3 months 
(n=18); 
 
Fear of breast cancer treatment - 57.7 (Mean) 65.9 (Mean) - There was no significant difference in 
mean level of fear about breast cancer 
treatment between the short and long TTP 
groups (p=0.37); Fear of treatment was 
not associated with TTP (r=0.06, p>0.05) 
Nosarti  
2000  
[47] 
> 27 days  
(n=242) 
Scared / Fear of cancer diagnosis - - 6.5% (17 4.9% (34) Scared/ Fear of cancer diagnosis was 
associated with longer TTP (OR=4.79 
CI=2.25-10.24) 
 
Burgess 
1998  
[44] 
>3 months 
(n=36) 
Fear on 
discovery of 
symptom 
‘Mild/no’ - 71% (99)  89% (31)  - Long TTP group reported less fear than 
short TTP group (but not significantly 
different, p=0.05) 
Fear was not an independent predictor of 
late presentation (statistical information 
not given) 
‘Marked/ 
moderate’ 
- 29% (41) 
 
11% (4) 
 
- 
                                                          
9 This was not considered as significant in the study as they corrected for type-1 error (only p < 0.001 was considered significant) 
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Burgess 
2006  
[43] 
 >12 weeks 
(n=29) 
Fear in response 
to symptom 
discovery 
‘Mild/no’ - 70% (28)  86% (25)  - There was no significant difference in 
levels of fear on discovery of symptom 
between the long TTP and short TTP 
group (Fisher exact test, p>0.05). 
 
‘Marked/ 
moderate’ 
- 30% (12) 
 
14% (4) 
 
- 
Fear of 
consequences of 
diagnosis or 
medical 
treatment of 
cancer 
‘Some’ - 8% (3) 28% (8) - Long TTP group reported ‘some’ fear of 
consequences of medical treatment 
significantly more often compared to the 
short TTP group, who more often 
reported ‘none’ (Fisher exact test, 
p<0.05) 
‘None’ - 93% (37) 72% (21) - 
O’Mahony 
2009  
[48] 
> 1 month (n=26) Afraid on discovery of breast 
symptom(s) 
- 32.9% (24) 23.0% (6) - There was no significant association 
between Afraid on discovery of breast 
symptom(s) and TTP (statistical 
information not given) 
Scared on discovery of breast 
symptom(s) 
- 30.1% (22) 19.2% (5) - There was no significant association 
between Scared on discovery of breast 
symptom(s) and TTP (statistical 
information not given) 
Cameron 
1968 
[50] 
> 3 months 
(n=17) 
 
Fear of 
operation 
Very confident  - - - 7% There was no significant association 
between Fear of operation and TTP 
(statistical information not given) 
 
Confident  - - - 24% 
Fairly confident  - - - 18% 
Nervous  - - - 27% 
Very nervous  - - - 23% 
> 1 year with 
cancer (n=6) 
Fear of malignancy not presenting earlier by: - 4.4% (1)10 -  
Fear of the consequences not presenting earlier by: - 4.4% (1) - 
Fear of hospitals not presenting earlier by: - 4.4% (1) - 
Fear of operation not presenting earlier by: - 4.4% (1) - 
 
  
                                                          
10 Those who acknowledged presenting late 
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Table 3: Impact of ‘worry’11 on TTP 
Author & 
year 
Definitions Results 
Cut-off point 
long TTP 
Specific worry Descriptive results Uni- or multivariate results 
Reported as reason 
for… 
Short TTP % 
(n) 
Long TTP % 
(n) 
Total sample 
% (n) 
Adam  
1980 
 [36] 
> 2 weeks 
(n=66) 
Too worried to approach GP not presenting earlier by:  - 3% (2)  - - 
Nothing to worry about not presenting earlier by: - 43.9% (29) - 
Lauver  
1995 
 [17] 
 
> 3 months 
(n=32) 
Fear/concern/worry: Feelings associated with 
symptoms 
Consultation by:  
 
- - 17.1% of total 
responses 
- 
General worry or fear about cancer in particular Consultation by: - - 14.2% of total 
responses 
Nichols  
1983 
 [34] 
12 weeks Nothing to worry about not presenting earlier by: 
 
- 9% (36) 12 3.1% (12) - 
Brochez  
2001  
[58] 
No cut-off Worry / anxiety about the lesion consultation by: - - 40% (52) Worried patients tended to have longer TTP but 
worry/anxiety about the lesion was not 
significantly associated with TTP (p>0.05) 
Bradley  
2005  
[42] 
No cut-off Worry about initial breast cancer symptom - - - - There was no significant association between 
worry about initial breast cancer symptom and 
TTP (statistical information not given) 
Worry about breast cancer diagnosis - - - - There was no significant association between 
worry about breast cancer diagnosis and TTP 
(statistical information not given) 
Cameron  
1968 
[50] 
 
 
> 3 months 
(n=17) 
Anxiety on 
discovering the 
lump in the breast 
Very, moderately or 
mildly worried 
- 85% (56) 15% (10)  Very: 43%, 
Moderately: 29% 
Mildly: 10% 
More worry among the short TTP group than 
long TTP group (X²=6.4, p<0.02).  
Slightly or not worried - 50% (7) 50% (7) Slightly: 11% 
Not at all: 6% 
Anxiety Consultation by 24.4% (10) - - - 
O’Mahony 
2009 
 [48] 
> 1 month (n=26) Anxious on discovery of breast symptom(s) - 43.8% (32) 23.0% (6) - Anxious on discovery of breast symptoms was 
associated with shorter TTP (r=-0.31, p<0.01) 
Hashim  
2010 
 [54] 
 
> 2 weeks (n=48) Worry/concern of 
rectal bleeding 
‘Not/little’  - 16.7% (7) 83.3% (35) -  ‘Not/little’ worried/concerned was a predictor of 
long TTP (Adjusted OR 4.7; CI 1.36-16.71) ‘Worried/ very worried’ - 65.8% (25) 34.2% (13) - 
                                                          
11 n presenting late for each cancer groups was not given 
12 Of the ‘reluctant’ group. Being reluctant  
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Coates  
1992  
[45] 
 
 
 
No cut-off Worry/ concern 
about breast 
symptoms 
‘Not worried’ - - - - ‘Worried and thinking it is serious’ (median 
TTP=10days; RR 1.40; CI 1.09-1.80) and 
‘worried and thinking it is cancer’ (median 
TTP=13days, RR 1.49; CI 1.23-1.79) had 
significantly shorter TTP than the patients who 
were ‘not worried’ (median TTP=28days) 
‘Worried but not serious’ - - - - 
‘Worried and serious’ - - - - 
‘Worried and cancer’ - - - - 
Coates  
1998  
[57] 
No cut-off ‘Worry’/’Concern’ ‘Not worried’ - - - - Those ‘worried and thinking it is serious’ (RR 
1.43; CI 1.02-2.01) had a significantly shorter 
TTP than patients who were ‘not worried’. 
 
‘Worried but not serious’ - - - - 
‘Worried and serious’ - - - - 
‘Worried and cancer’ - - - - 
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Table 4: Impact of other emotions on TTP 
Author & 
year  
Definitions Results 
Cut-off point long 
TTP 
Specific 
embarrassment 
or shame 
Descriptive results Uni- or multivariate results 
Reported as reason for… Short TTP % (n) Long TTP % (n) Total sample % (n) 
Henderson 
1966 [56] 
 >3 months (n=38) Embarrassed at 
being examined 
by a doctor 
not presenting earlier by: 0% (0) 13.1% (5) - - 
Nichols  
1983 
[34] 
Medium >4-12 
Long 12wks (not used 
in results) 
‘Embarrassment’ 
 
not presenting earlier by13 - 16% (63)  5.5% 
 
- 
Skeppner 
2012 
[41] 
Four groups: < 3 
months; 3-6 months; 
6-12 months; >1 year 
‘Embarrassment’ not presenting earlier by: < 3 months: 2.08% (1) 
3-6 months: 2.08% (1) 
 
6-12 months: 6.25% (3) 
>1 year: 18.75% (9) 
 
- - 
Ermiah 
2012 [51] 
No cut-off ‘Shame’ not presenting earlier by: 
 
- - 4.5% (9) - 
O’Mahony 
2009 
[48] 
> 1 month (n=26) Distressed on 
discovery of 
breast symptom(s) 
- 16.4% (12) 11.5% (3) -  There was no significant association between 
Distressed, Depressed or Angry on discovery 
of breast symptom(s) and TTP (statistical 
information not given) Depressed on 
discovery of 
breast symptom(s) 
- 4.1% (3) 7.7% (2) - 
Angry on 
discovery of 
breast symptom(s) 
- 2.7% (2) 3.8% (1) - 
Meechan  
2003  
[29] 
> 3 months (n=18) Emotional response to symptom discovery. Sum 
of: Afraid, anxious, distressed, scared 
10.5 (mean) 9.3 (mean) - Higher levels emotional response were 
associated with shorter TTP (r=-0.29, 
p<0.05); Emotional response was a 
significant independent predictor of TTP 
(continuous variable) (B=-0.32; t=-3.03; 
p<0.01); There was no significant difference 
in mean emotional response between the 
short and long TTP group (p=0.36) 
Scott  
2008 
[49] 
>31 days  
(n=43) 
Initial emotional response to the detection of an 
oral symptom. Sum of: 
Afraid, anxious, distressed, scared, concerned. 
10.6 (mean) 10.4 (mean) - Initial emotional response was not associated 
with TTP (OR 0.99; CI 0.90-1.09) 
                                                          
13
 Of the ‘reluctant’ group. Being reluctant correlated with long TTP (p<0.005) 
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Table 5: Summary of the role of emotions in TTP from uni- and multivariate studies. 
 
Emotion construct Impact on TTP Study Site 
Longer 
TTP 
No 
significant 
relationship 
Shorter 
TTP 
1. Non-specific emotions 
 
Fear  √  [31] Breast 
Worry/concern (+ thinking it was serious)
 14
   √ [57] Uterus 
2. Specific emotions 
 
Fear of cancer treatment √  
√ 
 [43] 
[29] 
Breast 
Breast 
Fear of mastectomy, operation or breast loss  √ 
√ 
 [53] 
[50] 
Breast 
Breast 
Fear of dying  √  [53] Breast 
Fear (or afraid) of diagnosis √  
√ 
 [47] 
[55] 
Breast 
Colorectal 
Fear about cancer or malignancy  √  [17] Breast 
Fear of disease  √  [53] Breast 
Worry about breast cancer diagnosis  √  [42] Breast 
Fear about implications √15   [30] Breast 
3. Emotions in response to symptom discovery 
 
Worry or anxiety about symptoms or lesion 
 
 
 
 
 
 
 
 
 
√ 
√ 
√ 
√ 
√ 
√ 
[50] 
[48] 
[45] 
[54] 
[42] 
[58] 
Breast 
Breast 
Breast 
Colorectal 
Breast 
Cutaneous melanoma 
Fear/afraid/scared in response to symptom 
discovery 
 
 
√ 
√ 
√ 
 
 
 
 
√16 
[43] 
[44] 
[48] 
[30] 
Breast 
Breast 
Breast 
Breast  
General Emotional response to symptom 
discovery (scale) 
 √  
√ 
[49] 
[29] 
Oral 
Breast 
Distressed in response to symptom discovery  √  [48] Breast 
Depressed in response to symptom discovery  √  [48] Breast 
Angry in response to symptom discovery   √  [48] Breast 
 
                                                          
14
 In comparison to ‘Not worried/concerned’, ‘Worry/concern and thinking it was not serious’ and 
‘Worry/concern and thinking it was cancer’  [57]  
15
 Fear of implications was associated with longer ‘utilisation delay’ (but not TTP) for those diagnosed with 
cancer (but not those with benign disease) 
16
 For those with benign disease but not those diagnosed with cancer. This emotion was related to shorter 
‘appraisal delay’ for those with benign disease and shorter ‘utilisation delay’, for those diagnosed with cancer. 
 
